milrinone has been researched along with natriuretic peptide, c-type in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotton, CU; Drumm, ML; Kelley, TJ | 1 |
| Herring, N; Paterson, DJ; Zaman, JA | 1 |
| Cho, KW; Cui, X; Jin, JY; Kim, SH; Kim, SM; Kim, SZ; Lee, HS; Wen, JF | 1 |
| Adamczyk, A; Azer, J; Bissell, MB; Hua, R; McBoyle, S; Robbins, C; Rose, RA; Springer, J | 1 |
4 other study(ies) available for milrinone and natriuretic peptide, c-type
| Article | Year |
|---|---|
Regulation of amiloride-sensitive sodium absorption in murine airway epithelium by C-type natriuretic peptide.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Absorption; Amiloride; Animals; Biological Transport; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelium; Membrane Potentials; Mice; Milrinone; Mutation; Nasal Mucosa; Natriuretic Peptide, C-Type; Phosphodiesterase Inhibitors; Proteins; Pyridones; Sodium; Trachea | 1998 |
Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
Topics: Acetylcholine; Animals; Atrial Natriuretic Factor; Bradycardia; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Cyclic GMP; Enzyme Inhibitors; Female; Gene Expression; Guanylate Cyclase; Guinea Pigs; Heart Rate; Isoquinolines; Milrinone; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; omega-Conotoxins; Phosphodiesterase Inhibitors; Polysaccharides; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Sulfonamides; Synaptic Transmission; Tritium; Vagus Nerve | 2001 |
High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Atrial Natriuretic Factor; Biological Transport; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Inhibitors; Guanylate Cyclase; Heart Atria; Milrinone; Molsidomine; Myocardial Contraction; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Nitric Oxide Donors; Oxadiazoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazoles; Pyridines; Quinoxalines; Rabbits; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Soluble Guanylyl Cyclase; Stroke Volume | 2004 |
The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Atrial Function; Atrial Natriuretic Factor; Electric Conductivity; Guanylate Cyclase; Heart Atria; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Milrinone; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Patch-Clamp Techniques; Peptide Fragments; Phosphodiesterase 3 Inhibitors; Receptors, Atrial Natriuretic Factor; Sinoatrial Node; Stimulation, Chemical; Tetrahydroisoquinolines | 2012 |